Cargando…
Three different mutations in the DNA topoisomerase 1B in Leishmania infantum contribute to resistance to antitumor drug topotecan
BACKGROUND: The evolution of drug resistance is one of the biggest challenges in leishmaniasis and has prompted the need for new antileishmanial drugs. Repurposing of approved drugs is a faster and very attractive strategy that is gaining supporters worldwide. Different anticancer topoisomerase 1B (...
Autores principales: | Rosa-Teijeiro, Chloé, Wagner, Victoria, Corbeil, Audrey, d’Annessa, Ilda, Leprohon, Philippe, do Monte-Neto, Rubens L., Fernandez-Prada, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8399852/ https://www.ncbi.nlm.nih.gov/pubmed/34454601 http://dx.doi.org/10.1186/s13071-021-04947-4 |
Ejemplares similares
-
Structural and Dynamical Effects Induced by the Anticancer Drug Topotecan on the Human Topoisomerase I – DNA Complex
por: Mancini, Giordano, et al.
Publicado: (2010) -
ATP independent type IB topoisomerase of Leishmania donovani is stimulated by ATP: an insight into the functional mechanism
por: Sengupta, Souvik, et al.
Publicado: (2011) -
MRPA-independent mechanisms of antimony resistance in Leishmania infantum
por: Douanne, Noélie, et al.
Publicado: (2020) -
Development of Derivatives of 3, 3′-Diindolylmethane as Potent Leishmania donovani Bi-Subunit Topoisomerase IB Poisons
por: Roy, Amit, et al.
Publicado: (2011) -
Drug resistance analysis by next generation sequencing in Leishmania
por: Leprohon, Philippe, et al.
Publicado: (2014)